Rebagen Uses, Dosage, Side Effects and more
Rebagen has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
| Trade Name | Rebagen |
| Generic | Rebamipide |
| Rebamipide Other Names | Rebamipida, Rebamipide, Rébamipide, Rebamipidum |
| Weight | 100mg |
| Type | Tablet |
| Formula | C19H15ClN2O4 |
| Weight | Average: 370.79 Monoisotopic: 370.0720347 |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | Macleods Pharmaceuticals |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Rebagen is a gastroprotective agent used in combination with other similar therapies (e.g. proton pump inhibitors) to treat gastritis and protect the gastric mucosa.
Rebagen is also used to associated treatment for these conditions: Gastric Ulcer
Food Interaction
- Take with or without food. Food does not impact the bioavailability of rebamipide.
